phosphorylcholine has been researched along with Infant, Premature, Diseases in 14 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Infant, Premature, Diseases: Diseases that occur in PREMATURE INFANTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pulmonary hemorrhage was present in 55% of 159 infants undergoing autopsy; the incidence was not different in infants treated with surfactant or air placebo." | 2.67 | Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. ( Derleth, D; Finer, N; Long, W; McMurray, B; Mullett, M; Peliowski, A; Sankaran, K; van Houten, J; Walker, D; Wold, D, 1992) |
| "A haemodynamically significant patent ductus arteriosus was clinically evident significantly earlier in babies who had received Survanta (mean age 1." | 1.29 | Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation. ( Malathi, I; Ng, KC, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (78.57) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moen, MD | 1 |
| Perry, CM | 1 |
| Wellington, K | 1 |
| Corbet, A | 4 |
| Gerdes, J | 2 |
| Long, W | 5 |
| Avila, E | 1 |
| Puri, A | 1 |
| Rosenberg, A | 1 |
| Edwards, K | 3 |
| Cook, L | 1 |
| Choukroun, ML | 2 |
| Llanas, B | 1 |
| Apere, H | 1 |
| Fayon, M | 2 |
| Galperine, RI | 1 |
| Guenard, H | 2 |
| Demarquez, JL | 2 |
| Bratlid, D | 1 |
| Farstad, T | 1 |
| Malathi, I | 1 |
| Ng, KC | 1 |
| Todd, DA | 1 |
| Kays, C | 1 |
| Galpérine, I | 1 |
| Rimensberger, PC | 1 |
| Beghetti, M | 1 |
| Hanquinet, S | 1 |
| Berner, M | 1 |
| Suresh, GK | 1 |
| Soll, RF | 1 |
| Bose, C | 1 |
| Bose, G | 1 |
| Prats, JG | 1 |
| Russell, L | 1 |
| Goldman, SL | 1 |
| Bosque, E | 1 |
| McCann, E | 1 |
| Lewis, K | 1 |
| Stevenson, D | 1 |
| Walther, F | 1 |
| Sell, M | 1 |
| Pauly, T | 1 |
| Gong, A | 1 |
| Easa, D | 1 |
| Pramanik, A | 1 |
| LeBlanc, M | 1 |
| Anday, E | 1 |
| van Houten, J | 1 |
| Mullett, M | 1 |
| Finer, N | 1 |
| Derleth, D | 1 |
| McMurray, B | 1 |
| Peliowski, A | 1 |
| Walker, D | 1 |
| Wold, D | 1 |
| Sankaran, K | 1 |
| Allen, A | 1 |
| McMillan, D | 1 |
| Boros, S | 1 |
| Vaughan, R | 1 |
| Houle, L | 1 |
| Schiff, D | 1 |
| Cotton, R | 1 |
| Courtney, S | 1 |
| McGuiness, G | 1 |
| Walter, D | 1 |
| Watts, J | 1 |
| Smyth, J | 1 |
| Bard, H | 1 |
| Chernick, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Open Lung Maneuvers During High Frequency Oscillatory Ventilation in Extremely Preterm Infants - A Single Center Randomized Controlled Trial[NCT04289324] | 36 participants (Anticipated) | Interventional | 2020-02-25 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for phosphorylcholine and Infant, Premature, Diseases
| Article | Year |
|---|---|
Lucinactant: in neonatal respiratory distress syndrome.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Animals, Newborn; Biological Products; Drug Combination | 2005 |
10 trials available for phosphorylcholine and Infant, Premature, Diseases
| Article | Year |
|---|---|
Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa.
Topics: Bronchopulmonary Dysplasia; Cause of Death; Double-Blind Method; Drug Administration Schedule; Drug | 1995 |
Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.
Topics: Airway Resistance; Biological Products; Combined Modality Therapy; Drug Combinations; Fatty Alcohols | 1994 |
[Natural and synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
Topics: Biological Products; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Infant, Premature, | 1994 |
Respiratory mechanics before and after late artificial surfactant rescue.
Topics: Age Factors; Combined Modality Therapy; Drug Combinations; Fatty Alcohols; Female; Humans; Hyaline M | 1995 |
Results of laboratory surveillance of very low birth weight infants treated with a synthetic surfactant.
Topics: Blood; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; | 1992 |
Pulmonary mechanics in premature infants one month after treatment with synthetic surfactant.
Topics: Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Humans; Infant, Newborn; Infant, Pre | 1992 |
Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.
Topics: Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Double-Blind Method; Drug Combinations; Ductus Arte | 1992 |
Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Topics: Autopsy; Double-Blind Method; Drug Combinations; Fatty Alcohols; Hemorrhage; Humans; Incidence; Infa | 1992 |
Retrospective search for bleeding diathesis among premature newborn infants with pulmonary hemorrhage after synthetic surfactant treatment. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Topics: Double-Blind Method; Drug Combinations; Fatty Alcohols; Hemorrhagic Disorders; Humans; Infant, Newbo | 1992 |
A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Topics: Birth Weight; Bronchopulmonary Dysplasia; Child; Drug Combinations; Fatty Alcohols; Female; Follow-U | 1991 |
3 other studies available for phosphorylcholine and Infant, Premature, Diseases
| Article | Year |
|---|---|
Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation.
Topics: Biological Products; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Drug Combinations; Ductus Arte | 1995 |
First intention high-frequency oscillation with early lung volume optimization improves pulmonary outcome in very low birth weight infants with respiratory distress syndrome.
Topics: Drug Combinations; Fatty Alcohols; Female; High-Frequency Ventilation; Humans; Infant, Newborn; Infa | 2000 |
Current surfactant use in premature infants.
Topics: Drug Combinations; Fatty Alcohols; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Pho | 2001 |